Xiang-Pan Meng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Xiang-Pan Meng has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
- Shenghong Ju
Cultivation and Construction Site of the State Key Laboratory of Intelligent Imaging and Interventional Medicine, Department of Radiology, Zhongda Hospital, Medical School of Southeast University, Nanjing, China
5 shared publications Qian Yu
3 shared publications- Tianyu Tang
Nurturing Center of Jiangsu Province for the State Laboratory of AI Imaging and Interventional Radiology, Department of Radiology, Zhongda Hospital, School of Medicine, Southeast University, 87 Dingjiaqiao Road, Nanjing 210009, Jiangsu, China (T.T.).
3 shared publications - Wenbo Xiao
Department of Radiology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
3 shared publications - Xueying Long
Department of Radiology, Xiangya Hospital, Central South University, Changsha, China
3 shared publications Yongping Zhou
Department of Hepatobiliary Surgery, Wuxi No.2 People's Hospital, Jiangnan University Medical Center, Affiliated Wuxi Clinical College of Nantong University, Wuxi, China
3 shared publications
Latest Publications
- 12 May 2026
- Published by Springer Nature in European Radiology
- Vol. 36 (9) , 6899-6911
CT-based Node-RADS for evaluating regional lymph node metastasis and postoperative recurrence in patients with pancreatic ductal adenocarcinoma undergoing upfront surgery
To evaluate the diagnostic performance of preoperative CT-based Node-RADS for regional lymph node (LN) metastasis and its prognostic value for postoperative recurrence in pancreatic ductal adenocarcinoma (PDAC). This single-center retrospective study included patients with PDAC undergoing contrast-enhanced CT and surgical resection between January 2017 and July 2023. Node-RADS scores were independently assigned for each resected LN station, with histopathology as the reference standard. Diagnostic performance was evaluated at the patient, LN group, and station levels using sensitivity, specificity, and the area under the receiver operating characteristic curve (AUC). Fine-Gray analysis was performed to assess the prognostic association of Node-RADS on time to recurrence (TTR) after adjustment for clinicopathologic variables. A total of 216 patients (mean age, 66.6 ± 9.1 years; 122 men) were included, with LN metastases in 154 (71.3%). Using a cutoff of Node-RADS ≥ 3, the sensitivity and specificity for detecting LN metastasis were 77.3% (119 of 154) and 83.9% (52 of 62) at the patient level, 74.8% (104 of 139) and 81.8% (63 of 77) for group 1, and 77.3% (34 of 44) and 82.6% (142 of 172) for group 2, with AUCs corresponding of 0.815, 0.791, and 0.814. Per-station analysis showed sensitivity ranging from 60.0% to 84.6% and specificity from 79.1% to 97.7%. Multivariable Fine-Gray analyses confirmed that Node-RADS ≥ 3 independently predicted shorter TTR (subdistribution hazard ratio, 1.68; 95% CI: 1.19-2.36; p = 0.003). Preoperative CT-based Node-RADS enabled promising assessment of regional LN metastasis and prediction of postoperative recurrence in PDAC. Question Accurate preoperative identification of regional LN metastasis in PDAC remains challenging, limiting prognosis assessment and individualized treatment allocation. Findings Node-RADS ≥ 3 on preoperative CT demonstrates robust diagnostic performance across patient, group, and station levels and independently predicts shorter recurrence-free survival in PDAC. Clinical relevance CT-based Node-RADS provides promising preoperative assessment of regional nodal involvement and recurrence prediction in PDAC, facilitating personalized surgical planning and decision-making regarding neoadjuvant therapy.
- 12 May 2026
- Published by Springer Nature in European Radiology
- Vol. 36 (9) , 6899-6911
CT-based Node-RADS for evaluating regional lymph node metastasis and postoperative recurrence in patients with pancreatic ductal adenocarcinoma undergoing upfront surgery
To evaluate the diagnostic performance of preoperative CT-based Node-RADS for regional lymph node (LN) metastasis and its prognostic value for postoperative recurrence in pancreatic ductal adenocarcinoma (PDAC). This single-center retrospective study included patients with PDAC undergoing contrast-enhanced CT and surgical resection between January 2017 and July 2023. Node-RADS scores were independently assigned for each resected LN station, with histopathology as the reference standard. Diagnostic performance was evaluated at the patient, LN group, and station levels using sensitivity, specificity, and the area under the receiver operating characteristic curve (AUC). Fine-Gray analysis was performed to assess the prognostic association of Node-RADS on time to recurrence (TTR) after adjustment for clinicopathologic variables. A total of 216 patients (mean age, 66.6 ± 9.1 years; 122 men) were included, with LN metastases in 154 (71.3%). Using a cutoff of Node-RADS ≥ 3, the sensitivity and specificity for detecting LN metastasis were 77.3% (119 of 154) and 83.9% (52 of 62) at the patient level, 74.8% (104 of 139) and 81.8% (63 of 77) for group 1, and 77.3% (34 of 44) and 82.6% (142 of 172) for group 2, with AUCs corresponding of 0.815, 0.791, and 0.814. Per-station analysis showed sensitivity ranging from 60.0% to 84.6% and specificity from 79.1% to 97.7%. Multivariable Fine-Gray analyses confirmed that Node-RADS ≥ 3 independently predicted shorter TTR (subdistribution hazard ratio, 1.68; 95% CI: 1.19-2.36; p = 0.003). Preoperative CT-based Node-RADS enabled promising assessment of regional LN metastasis and prediction of postoperative recurrence in PDAC. Question Accurate preoperative identification of regional LN metastasis in PDAC remains challenging, limiting prognosis assessment and individualized treatment allocation. Findings Node-RADS ≥ 3 on preoperative CT demonstrates robust diagnostic performance across patient, group, and station levels and independently predicts shorter recurrence-free survival in PDAC. Clinical relevance CT-based Node-RADS provides promising preoperative assessment of regional nodal involvement and recurrence prediction in PDAC, facilitating personalized surgical planning and decision-making regarding neoadjuvant therapy.
- 17 April 2026
- Published by Elsevier in European Journal of Radiology
- Vol. 200, 112879
Comparison of Node-RADS for regional lymph node metastasis in pancreatic ductal adenocarcinoma via CT and MRI
- 17 April 2026
- Published by Elsevier in European Journal of Radiology
- Vol. 200, 112879
Comparison of Node-RADS for regional lymph node metastasis in pancreatic ductal adenocarcinoma via CT and MRI
- Open Access
- 25 August 2025
- Published by Elsevier in JHEP Reports
- Vol. 7 (11)
Anatomical resection is associated with reduced early recurrences in HCC: A machine learning analysis
- 25 August 2025
- Published by Elsevier in JHEP Reports
- Vol. 7 (11)
Open AccessAnatomical resection is associated with reduced early recurrences in HCC: A machine learning analysis
- Open Access
- 1 June 2023
- Published by Elsevier in JHEP Reports
- Vol. 5 (9) , 100806
Predicting post-resection recurrence by integrating imaging-based surrogates of distinct vascular patterns of hepatocellular carcinoma
- 1 June 2023
- Published by Elsevier in JHEP Reports
- Vol. 5 (9) , 100806
Open AccessPredicting post-resection recurrence by integrating imaging-based surrogates of distinct vascular patterns of hepatocellular carcinoma
- Top Cited Papers
- 1 May 2023
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 307 (4) , 222729
Predicting Microvascular Invasion in Hepatocellular Carcinoma Using CT-based Radiomics Model
Background Prediction of microvascular invasion (MVI) may help determine treatment strategies for hepatocellular carcinoma (HCC). Purpose To develop a radiomics approach for predicting MVI status based on preoperative multiphase CT images and to identify MVI-associated differentially expressed genes. Materials and Methods Patients with pathologically proven HCC from May 2012 to September 2020 were retrospectively included from four medical centers. Radiomics features were extracted from tumors and peritumor regions on preoperative registration or subtraction CT images. In the training set, these features were used to build five radiomics models via logistic regression after feature reduction. The models were tested using internal and external test sets against a pathologic reference standard to calculate area under the receiver operating characteristic curve (AUC). The optimal AUC radiomics model and clinical-radiologic characteristics were combined to build the hybrid model. The log-rank test was used in the outcome cohort (Kunming center) to analyze early recurrence-free survival and overall survival based on high versus low model-derived score. RNA sequencing data from The Cancer Image Archive were used for gene expression analysis. Results A total of 773 patients (median age, 59 years; IQR, 49-64 years; 633 men) were divided into the training set (n = 334), internal test set (n = 142), external test set (n = 141), outcome cohort (n = 121), and RNA sequencing analysis set (n = 35). The AUCs from the radiomics and hybrid models, respectively, were 0.76 and 0.86 for the internal test set and 0.72 and 0.84 for the external test set. Early recurrence-free survival (P < .01) and overall survival (P < .007) can be categorized using the hybrid model. Differentially expressed genes in patients with findings positive for MVI were involved in glucose metabolism. Conclusion The hybrid model showed the best performance in prediction of MVI. © RSNA, 2023 Supplemental material is available for this article. See also the editorial by Summers in this issue.
- 1 May 2023
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 307 (4) , 222729
Top Cited PapersPredicting Microvascular Invasion in Hepatocellular Carcinoma Using CT-based Radiomics Model
Background Prediction of microvascular invasion (MVI) may help determine treatment strategies for hepatocellular carcinoma (HCC). Purpose To develop a radiomics approach for predicting MVI status based on preoperative multiphase CT images and to identify MVI-associated differentially expressed genes. Materials and Methods Patients with pathologically proven HCC from May 2012 to September 2020 were retrospectively included from four medical centers. Radiomics features were extracted from tumors and peritumor regions on preoperative registration or subtraction CT images. In the training set, these features were used to build five radiomics models via logistic regression after feature reduction. The models were tested using internal and external test sets against a pathologic reference standard to calculate area under the receiver operating characteristic curve (AUC). The optimal AUC radiomics model and clinical-radiologic characteristics were combined to build the hybrid model. The log-rank test was used in the outcome cohort (Kunming center) to analyze early recurrence-free survival and overall survival based on high versus low model-derived score. RNA sequencing data from The Cancer Image Archive were used for gene expression analysis. Results A total of 773 patients (median age, 59 years; IQR, 49-64 years; 633 men) were divided into the training set (n = 334), internal test set (n = 142), external test set (n = 141), outcome cohort (n = 121), and RNA sequencing analysis set (n = 35). The AUCs from the radiomics and hybrid models, respectively, were 0.76 and 0.86 for the internal test set and 0.72 and 0.84 for the external test set. Early recurrence-free survival (P < .01) and overall survival (P < .007) can be categorized using the hybrid model. Differentially expressed genes in patients with findings positive for MVI were involved in glucose metabolism. Conclusion The hybrid model showed the best performance in prediction of MVI. © RSNA, 2023 Supplemental material is available for this article. See also the editorial by Summers in this issue.
- Open Access
- 27 August 2022
- Published by Elsevier in JHEP Reports
- Vol. 4 (11) , 100575
Spleen volume-based non-invasive tool for predicting hepatic decompensation in people with compensated cirrhosis (CHESS1701)
- 27 August 2022
- Published by Elsevier in JHEP Reports
- Vol. 4 (11) , 100575
Open AccessSpleen volume-based non-invasive tool for predicting hepatic decompensation in people with compensated cirrhosis (CHESS1701)
- 11 February 2022
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 29 (5) , 2973-2974
ASO Visual Abstract: Preoperative Microvascular Invasion Prediction to Assist in the Surgical Plan for Single Hepatocellular Carcinoma: Better Together With Radiomics
- 11 February 2022
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 29 (5) , 2973-2974
ASO Visual Abstract: Preoperative Microvascular Invasion Prediction to Assist in the Surgical Plan for Single Hepatocellular Carcinoma: Better Together With Radiomics